In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic fibrosis

C. M. Sloan; L. J. Sherrard; G. G. Einarsson; L. R. Hoffman; M. M. Tunney; D. G. Downey

doi:10.1016/S1569-1993(23)00600-8

In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic fibrosis

C. M. Sloan, L. J. Sherrard, G. G. Einarsson, L. R. Hoffman, M. M. Tunney, D. G. Downey

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	P228
Pages (from-to)	S135
Number of pages	1
Journal	Journal of Cystic Fibrosis
Volume	22
Issue number	Supplement 2
DOIs	https://doi.org/10.1016/S1569-1993(23)00600-8
Publication status	Published - 01 Jun 2023
Event	46th European Cystic Fibrosis Conference 2023 - Vienna, Austria Duration: 07 Jun 2023 → 10 Jun 2023

Access to Document

10.1016/S1569-1993(23)00600-8Licence: Unspecified

Levofloxacin: reducing the risk of Pseudomonas aeruginosa resistance
Sloan, C. M. (Author), Downey, D. (Supervisor) & Sherrard, L. (Supervisor), Dec 2024
Student thesis: Doctoral Thesis › Doctor of Philosophy

Cite this

Sloan, C. M., Sherrard, L. J., Einarsson, G. G., Hoffman, L. R., Tunney, M. M., & Downey, D. G. (2023). In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic fibrosis. Journal of Cystic Fibrosis, 22(Supplement 2), S135. Article P228. https://doi.org/10.1016/S1569-1993(23)00600-8

@article{83ee6fb00ce74d78b7b99b33070e91da,

title = "In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic fibrosis",

author = "Sloan, {C. M.} and Sherrard, {L. J.} and Einarsson, {G. G.} and Hoffman, {L. R.} and Tunney, {M. M.} and Downey, {D. G.}",

year = "2023",

month = jun,

day = "1",

doi = "10.1016/S1569-1993(23)00600-8",

language = "English",

volume = "22",

pages = "S135",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier B.V.",

number = "Supplement 2",

note = "46th European Cystic Fibrosis Conference 2023, ECFS 2023 ; Conference date: 07-06-2023 Through 10-06-2023",

}

Sloan, CM, Sherrard, LJ , Einarsson, GG, Hoffman, LR, Tunney, MM & Downey, DG 2023, 'In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic fibrosis', Journal of Cystic Fibrosis, vol. 22, no. Supplement 2, P228, pp. S135. https://doi.org/10.1016/S1569-1993(23)00600-8

In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic fibrosis. / Sloan, C. M.; Sherrard, L. J.; Einarsson, G. G. et al.
In: Journal of Cystic Fibrosis, Vol. 22, No. Supplement 2, P228, 01.06.2023, p. S135.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic fibrosis

AU - Sloan, C. M.

AU - Sherrard, L. J.

AU - Einarsson, G. G.

AU - Hoffman, L. R.

AU - Tunney, M. M.

AU - Downey, D. G.

PY - 2023/6/1

Y1 - 2023/6/1

U2 - 10.1016/S1569-1993(23)00600-8

DO - 10.1016/S1569-1993(23)00600-8

M3 - Meeting abstract

SN - 1569-1993

VL - 22

SP - S135

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

IS - Supplement 2

M1 - P228

T2 - 46th European Cystic Fibrosis Conference 2023

Y2 - 7 June 2023 through 10 June 2023

ER -

In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic fibrosis

Access to Document

Fingerprint

Levofloxacin: reducing the risk of Pseudomonas aeruginosa resistance

Cite this

In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic fibrosis

Access to Document

Fingerprint

Student theses

Levofloxacin: reducing the risk of Pseudomonas aeruginosa resistance

Cite this